Regulation of carcinogenic food additives in the United States
Keywords:
food additive, Food Additive Petition (FAP), acesulfame, carcinogens, U.S. Food and Drug Administration (FDA), carcinogen bioassay, U.S. National Toxicology Program (NTP), saccharin, aspartame, olestraAbstract
Regulation of food additives, including carcinogenic food additives, in the United States, is the responsibility of the U.S. Food and Drug Administration (FDA). FDA has approved for marketing food additives that have not been demonstrated, using good testing methods, to be free of carcinogenic potential. Acesulfame potassium, a high-intensity artificial sweetener, is widely used in the United States, usually in blends with aspartame or sucralose. Acesulfame has never been tested in bioassays sufficient to resolve the question of whether the additive is free of carcinogenic potential. FDA’s decision-making regarding carcinogenic food additives has not necessarily been based on good science or protection of public health. Changes in the Food Additive Petition (FAP) approval process are needed to ensure that carcinogenic food additives do not get approved for marketing.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.